Skip to main content
INO
NASDAQ Life Sciences

Inovio Finalizes $80.5M Net Raise as Underwriters Take Full Option

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.37
Mkt Cap
$125.628M
52W Low
$0.563
52W High
$2.72
52W Position info
143% above low
Off High info
50% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

INO has more than doubled off its 52-week low of $0.563 on elevated volume (3.8× avg).

Summary

Inovio closed the books on its underwritten offering at $1.05 per share, with the full option exercised for about $80.5 million net — enough, management says, to fund operations into late fourth quarter 2027.


Key Events · Financing and Capital Events · INO

  • Offering Priced at $1.05, Option Fully Exercised

    58,747,235 shares at $1.05 plus pre-funded warrants for 12,681,337 shares at $1.049; underwriters exercised the full 10,714,285-share option on November 6, 2026.

  • Net Proceeds of About $80.5 Million

    Expected net proceeds are approximately $80.5 million after underwriting discounts and estimated offering expenses, versus roughly $75 million gross on the base deal.

  • Runway Extended to Late Q4 2027

    Management states net proceeds plus current cash, cash equivalents and short-term investments fund operating expenses and capital expenditure requirements into late fourth quarter 2027.

  • Deep Discount to Pre-Launch Price

    The $1.05 offering price compares with a $1.45 last reported sale before launch, a roughly 28% discount that shifts value to new buyers.


Analysis · INO · Life Sciences

Inovio locked in roughly $80.5 million net from its underwritten offering after Jefferies, Piper Sandler and H.C. Wainwright exercised the full 10,714,285-share option on November 6, 2026. The cash matters more than the mechanics: the company entered the year with a going-concern warning and runway only into late Q1 2027, and management now says proceeds plus existing cash fund operations into late fourth quarter 2027 — roughly three extra quarters of life. The price is the cost: shares and pre-funded warrants were sold at $1.05 and $1.049, against a $1.45 last reported sale before launch, so buyers got a steep discount and existing holders absorbed heavy dilution. The 90-day company lock-up and director/officer lock-ups limit further supply near term, but the overhang from 71.4 million new shares plus 12.7 million warrant shares is now a fixed part of the capital structure.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INO was trading at $1.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $125.6M. The 52-week trading range was $0.56 to $2.72. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INO - Latest Insights

INO
Nov 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.38 info
Change: +$0.1683 (+14%) info
Market Cap: $125.628M info
INO
Nov 05, 2026, 11:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.38 info
Change: +$0.1489 (+12%) info
Market Cap: $125.628M info
INO
Nov 05, 2026, 7:46 PM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $1.15
Real-time Price: $1.38 info
Change: +$0.2275 (+20%) info
Market Cap: $125.628M info
INO
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.24
Real-time Price: $1.38 info
Change: +$0.1383 (+11%) info
Market Cap: $125.628M info
INO
Nov 05, 2026, 4:10 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.38 info
Change: +$0.1783 (+15%) info
Market Cap: $125.628M info